WELL shares rose 1.6 percent Thursday after J.P. Morgan elevated the healthcare REIT to overweight from neutral, with analyst Michael Mueller setting a $260 price target—11 percent above the stock's Thursday close.
Mueller's upgrade reflects conviction that Welltower is positioned for several years of better-than-average growth. The primary driver: consistent net operating income expansion in senior housing, a segment benefiting from aging U.S. demographics and rising demand for senior living facilities.
The upgrade came as part of J.P. Morgan's broader reevaluation of REIT sector coverage. Mueller noted Welltower's operational strength is notable within both healthcare REITs and the broader real estate sector.
A trade-off for investors: Welltower's rising popularity among REIT investors has compressed its dividend yield to 1.5 percent, well below the sector average. REITs typically distribute most taxable income to shareholders, often yielding 3 percent or higher. Investors choosing Welltower are betting on capital appreciation and NOI growth over current income.
